Novel photoswitchable substrate for sphingomyelin synthase 2 (SMS2), enabling optical control of apoptosis and being ready for azide-alkyne click chemistry

Natural Potent Inhibitor of Transient Receptor Potential Melastatin 2 (TRPM2) Ion Channels

Natural selective non-peptide antagonist for the receptor GAL-1

Novel Inhibitor of the virus fusion to its cell receptor, targeting SARS-CoV-2 spike protein HR1

Novel Inhibitor of the virus fusion to its cell receptor, targeting SARS-CoV-2 spike protein HR1

Precursor for radioiosotopically labelled R(+)-SCH-23390

D1 dopamine receptor antagonist

Novel, orally active phosphodiesterase 4 (PDE4) inhibitor

Non-​nucleoside antiviral agent, having potent and selective activity against herpes simplex virus type 2 (HSV-​2)

Potent and selective PDE1 and PDE5 inhibitor

Novel Acyl_carrier_protein_synthase>acyl carrier protein synthase inhibitor; Inhibitor of growth of the bacteria Streptococcus_pneumoniae>Streptococcus pneumoniae and Neisseria_gonorrhoeae>Neisseria gonorrhoeae

Inhibitor of p21-hRas nucleotide exchange in vitro

Novel histamine H3-receptor antagonist

Novel potent and selective glucagon receptor antagonist

Novel inhibitor of SARS-CoV-2 main protease (MPro)

Novel inhibitor of vanilloid receptor subtype 1 (VR1)

Novel Lysine-Specific Demethylase 1 (LSD1) Inhibitor (IC50: 20nM)

Novel glucose transport inhibitor

Novel inhibitor of SARS-CoV-2 main protease (MPro)

Novel inhibitor of SARS-CoV-2 main protease (MPro)

Selective, ATP-competitive p38

Novel Inhibitor of p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs) with the IC50 values of 140, 910 and 17.5 nmol/L against MDM2, HDAC1, and HDAC6, respectively, showing the tumor growth inhibition (TGI) in the A549 xenograf